Newbold, K ;
Schoeffski, P ;
Hasan, B...
Newbold , K , Schoeffski , P , Hasan , B , Locati , L D , Godbert , Y , de la Fouchardiere , C , Bastholt , L , Fassnacht , M , Reed , N , Lalami , Y , Chougnet , C , Schvartz , C , Kapiteijn , E , Schlumberger , M J , Sents , W , Sauve , N & Leboulleux , S 2020 , ' Nintedanib (BIBF1120) after first line therapy in progressive medullary thyroid cancer: A multicenter EORTC prospective randomized double-blind phase II study (NCT01788982) ' , Annals of Oncology , vol. 31 , no. Suppl. 4 , 1919P , pp. S1087-S1088 . https://doi.org/10.1016/j.annonc.2020.08.1407.
,
2020